Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Moderna Inc has a consensus price target of $75.22 based on the ratings of 28 analysts. The high is $208 issued by Chardan Capital on January 18, 2023. The low is $33 issued by JP Morgan on March 21, 2025. The 3 most-recent analyst ratings were released by JP Morgan, Citigroup, and UBS on March 21, 2025, March 13, 2025, and February 19, 2025, respectively. With an average price target of $50.33 between JP Morgan, Citigroup, and UBS, there's an implied 46.74% upside for Moderna Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
03/21/2025 | Buy Now | -3.79% | JP Morgan | Jessica Fye68% | $40 → $33 | Maintains | Underweight | Get Alert |
03/13/2025 | Buy Now | 16.62% | Citigroup | Geoff Meacham63% | → $40 | Initiates | → Neutral | Get Alert |
02/19/2025 | Buy Now | 127.41% | UBS | Eliana Merle46% | $96 → $78 | Maintains | Buy | Get Alert |
02/18/2025 | Buy Now | 16.62% | RBC Capital | Luca Issi40% | $40 → $40 | Reiterates | Sector Perform → Sector Perform | Get Alert |
02/18/2025 | Buy Now | 31.2% | Barclays | Gena Wang50% | $111 → $45 | Downgrade | Overweight → Equal-Weight | Get Alert |
02/11/2025 | Buy Now | -0.87% | B of A Securities | Tim Anderson53% | $41 → $34 | Maintains | Underperform | Get Alert |
01/29/2025 | Buy Now | 48.69% | Goldman Sachs | Salveen Richter52% | $99 → $51 | Downgrade | Buy → Neutral | Get Alert |
01/28/2025 | Buy Now | 188.63% | Goldman Sachs | Salveen Richter52% | $112 → $99 | Maintains | Buy | Get Alert |
01/27/2025 | Buy Now | 45.77% | Evercore ISI Group | Cory Kasimov69% | $60 → $50 | Maintains | In-Line | Get Alert |
01/15/2025 | Buy Now | 10.79% | Morgan Stanley | Matthew Harrison60% | $70 → $38 | Maintains | Equal-Weight | Get Alert |
01/08/2025 | Buy Now | 179.88% | UBS | Eliana Merle46% | $108 → $96 | Maintains | Buy | Get Alert |
12/18/2024 | Buy Now | — | Argus Research | John Eade74% | — | Downgrade | Buy → Hold | Get Alert |
12/10/2024 | Buy Now | 19.53% | B of A Securities | Tim Anderson53% | → $41 | Reinstates | → Underperform | Get Alert |
11/26/2024 | Buy Now | 31.2% | JP Morgan | Jessica Fye68% | $59 → $45 | Maintains | Underweight | Get Alert |
11/18/2024 | Buy Now | 101.17% | Piper Sandler | Edward Tenthoff52% | $115 → $69 | Reiterates | Overweight → Overweight | Get Alert |
11/18/2024 | Buy Now | 69.1% | HSBC | Yifeng Liu39% | → $58 | Upgrade | Hold → Buy | Get Alert |
11/15/2024 | Buy Now | 16.62% | Wolfe Research | Alexandria Hammond43% | → $40 | Initiates | → Underperform | Get Alert |
11/08/2024 | Buy Now | 223.62% | Barclays | Gena Wang50% | $125 → $111 | Maintains | Overweight | Get Alert |
11/08/2024 | Buy Now | — | Needham | Joseph Stringer50% | — | Reiterates | → Hold | Get Alert |
11/04/2024 | Buy Now | 72.01% | JP Morgan | Jessica Fye68% | $70 → $59 | Maintains | Underweight | Get Alert |
10/24/2024 | Buy Now | 214.87% | UBS | Eliana Merle46% | $140 → $108 | Maintains | Buy | Get Alert |
10/17/2024 | Buy Now | 60.35% | Bernstein | Courtney Breen1% | → $55 | Initiates | → Market Perform | Get Alert |
10/15/2024 | Buy Now | 60.35% | Jefferies | Michael Yee56% | $65 → $55 | Maintains | Hold | Get Alert |
09/19/2024 | Buy Now | 118.66% | RBC Capital | Luca Issi40% | $75 → $75 | Reiterates | Sector Perform → Sector Perform | Get Alert |
09/16/2024 | Buy Now | 305.25% | Goldman Sachs | Salveen Richter52% | $178 → $139 | Maintains | Buy | Get Alert |
09/16/2024 | Buy Now | 264.43% | Barclays | Gena Wang50% | $155 → $125 | Maintains | Overweight | Get Alert |
09/13/2024 | Buy Now | 220.7% | B of A Securities | Geoff Meacham63% | $130 → $110 | Maintains | Neutral | Get Alert |
09/13/2024 | Buy Now | 235.28% | Piper Sandler | Edward Tenthoff52% | $157 → $115 | Maintains | Overweight | Get Alert |
09/13/2024 | Buy Now | 74.93% | TD Cowen | Tyler Van Buren48% | $70 → $60 | Maintains | Hold | Get Alert |
09/13/2024 | Buy Now | 118.66% | RBC Capital | Luca Issi40% | $90 → $75 | Maintains | Sector Perform | Get Alert |
09/13/2024 | Buy Now | 104.08% | JP Morgan | Jessica Fye68% | $88 → $70 | Downgrade | Neutral → Underweight | Get Alert |
09/13/2024 | Buy Now | 89.5% | Jefferies | Michael Yee56% | $120 → $65 | Downgrade | Buy → Hold | Get Alert |
09/13/2024 | Buy Now | — | Oppenheimer | Hartaj Singh47% | — | Downgrade | Outperform → Perform | Get Alert |
09/13/2024 | Buy Now | — | Needham | Joseph Stringer50% | — | Reiterates | → Hold | Get Alert |
08/28/2024 | Buy Now | 139.07% | HSBC | Yifeng Liu39% | → $82 | Upgrade | Reduce → Hold | Get Alert |
08/15/2024 | Buy Now | 156.56% | JP Morgan | Jessica Fye68% | $96 → $88 | Maintains | Neutral | Get Alert |
08/06/2024 | Buy Now | 133.24% | Deutsche Bank | Emmanuel Papadakis48% | $85 → $80 | Upgrade | Sell → Hold | Get Alert |
08/05/2024 | Buy Now | 162.39% | RBC Capital | Luca Issi40% | $125 → $90 | Downgrade | Outperform → Sector Perform | Get Alert |
08/02/2024 | Buy Now | 264.43% | RBC Capital | Luca Issi40% | $160 → $125 | Maintains | Outperform | Get Alert |
08/02/2024 | Buy Now | 418.95% | Goldman Sachs | Salveen Richter52% | $204 → $178 | Maintains | Buy | Get Alert |
08/02/2024 | Buy Now | 351.9% | Barclays | Gena Wang50% | $168 → $155 | Maintains | Overweight | Get Alert |
08/02/2024 | Buy Now | 357.73% | Piper Sandler | Edward Tenthoff52% | $214 → $157 | Reiterates | Overweight → Overweight | Get Alert |
08/01/2024 | Buy Now | — | Needham | Joseph Stringer50% | — | Reiterates | → Hold | Get Alert |
06/28/2024 | Buy Now | — | Needham | Joseph Stringer50% | — | Reiterates | → Hold | Get Alert |
06/27/2024 | Buy Now | 523.91% | Piper Sandler | Edward Tenthoff52% | $214 → $214 | Reiterates | Overweight → Overweight | Get Alert |
06/27/2024 | Buy Now | 249.85% | Evercore ISI Group | Cory Kasimov69% | $120 → $120 | Maintains | In-Line | Get Alert |
06/12/2024 | Buy Now | 179.88% | JP Morgan | Jessica Fye68% | $85 → $96 | Maintains | Neutral | Get Alert |
06/12/2024 | Buy Now | 421.87% | Oppenheimer | Hartaj Singh47% | $163 → $179 | Maintains | Outperform | Get Alert |
06/03/2024 | Buy Now | 366.47% | RBC Capital | Luca Issi40% | $135 → $160 | Maintains | Outperform | Get Alert |
06/03/2024 | Buy Now | — | Needham | Joseph Stringer50% | — | Reiterates | → Hold | Get Alert |
05/14/2024 | Buy Now | 249.85% | Evercore ISI Group | Cory Kasimov69% | → $120 | Initiates | → In-Line | Get Alert |
05/07/2024 | Buy Now | 340.23% | UBS | Eliana Merle46% | $143 → $151 | Maintains | Buy | Get Alert |
05/03/2024 | Buy Now | 209.04% | Canaccord Genuity | Bill Maughan19% | $91 → $106 | Maintains | Hold | Get Alert |
05/03/2024 | Buy Now | 293.59% | RBC Capital | Luca Issi40% | $125 → $135 | Maintains | Outperform | Get Alert |
05/03/2024 | Buy Now | 375.22% | Oppenheimer | Hartaj Singh47% | $142 → $163 | Maintains | Outperform | Get Alert |
05/02/2024 | Buy Now | — | Needham | Joseph Stringer50% | — | Reiterates | → Hold | Get Alert |
04/11/2024 | Buy Now | — | Needham | Joseph Stringer50% | — | Reiterates | → Hold | Get Alert |
04/09/2024 | Buy Now | 264.43% | Jefferies | Michael Yee56% | → $125 | Reiterates | Buy → Buy | Get Alert |
03/28/2024 | Buy Now | 264.43% | RBC Capital | Luca Issi40% | $125 → $125 | Reiterates | Outperform → Outperform | Get Alert |
03/28/2024 | Buy Now | — | Needham | Joseph Stringer50% | — | Reiterates | → Hold | Get Alert |
03/15/2024 | Buy Now | 147.81% | JP Morgan | Jessica Fye68% | $90 → $85 | Maintains | Neutral | Get Alert |
02/26/2024 | Buy Now | 150.73% | HSBC | Yifeng Liu39% | $75 → $86 | Downgrade | Hold → Reduce | Get Alert |
02/23/2024 | Buy Now | 264.43% | RBC Capital | Luca Issi40% | $125 → $125 | Reiterates | Outperform → Outperform | Get Alert |
02/23/2024 | Buy Now | 165.31% | Canaccord Genuity | Bill Maughan19% | $82 → $91 | Maintains | Hold | Get Alert |
01/12/2024 | Buy Now | 264.43% | RBC Capital | Luca Issi40% | $125 → $125 | Reiterates | Outperform → Outperform | Get Alert |
01/02/2024 | Buy Now | 313.99% | Oppenheimer | Hartaj Singh47% | → $142 | Upgrade | Perform → Outperform | Get Alert |
12/01/2023 | Buy Now | 162.39% | JP Morgan | Jessica Fye68% | $93 → $90 | Maintains | Neutral | Get Alert |
11/29/2023 | Buy Now | 139.07% | Canaccord Genuity | Bill Maughan19% | → $82 | Initiates | → Hold | Get Alert |
11/03/2023 | Buy Now | 264.43% | RBC Capital | Luca Issi40% | $180 → $125 | Maintains | Outperform | Get Alert |
11/03/2023 | Buy Now | 573.47% | Goldman Sachs | Salveen Richter52% | $269 → $231 | Maintains | Buy | Get Alert |
11/03/2023 | Buy Now | 101.17% | HSBC | Yifeng Liu39% | $89 → $69 | Upgrade | Reduce → Hold | Get Alert |
11/02/2023 | Buy Now | — | Deutsche Bank | Emmanuel Papadakis48% | — | Downgrade | Hold → Sell | Get Alert |
09/13/2023 | Buy Now | 308.16% | Argus Research | Jasper Hellweg70% | $160 → $140 | Maintains | Buy | Get Alert |
08/04/2023 | Buy Now | 258.6% | Morgan Stanley | Matthew Harrison60% | $128 → $123 | Maintains | Equal-Weight | Get Alert |
08/04/2023 | Buy Now | 337.32% | B of A Securities | Geoff Meacham63% | $175 → $150 | Maintains | Neutral | Get Alert |
08/04/2023 | Buy Now | 453.94% | RBC Capital | Luca Issi40% | $200 → $190 | Maintains | Outperform | Get Alert |
08/04/2023 | Buy Now | 264.43% | TD Cowen | Tyler Van Buren48% | $145 → $125 | Downgrade | Outperform → Market Perform | Get Alert |
08/03/2023 | Buy Now | 264.43% | Deutsche Bank | Emmanuel Papadakis48% | $200 → $125 | Downgrade | Buy → Hold | Get Alert |
07/24/2023 | Buy Now | 381.05% | TD Cowen | Tyler Van Buren48% | $175 → $165 | Maintains | Outperform | Get Alert |
07/24/2023 | Buy Now | — | William Blair | Myles Minter44% | — | Initiates | → Market Perform | Get Alert |
07/14/2023 | Buy Now | 182.8% | HSBC | Rajesh Kumar65% | → $97 | Initiates | → Reduce | Get Alert |
07/11/2023 | Buy Now | 273.18% | Morgan Stanley | Matthew Harrison60% | $153 → $128 | Maintains | Equal-Weight | Get Alert |
06/26/2023 | Buy Now | 456.85% | UBS | Eliana Merle46% | $221 → $191 | Upgrade | Neutral → Buy | Get Alert |
05/05/2023 | Buy Now | 462.68% | Morgan Stanley | Matthew Harrison60% | $185 → $193 | Maintains | Equal-Weight | Get Alert |
04/26/2023 | Buy Now | — | Guggenheim | Evan Wang8% | — | Initiates | → Neutral | Get Alert |
04/12/2023 | Buy Now | 308.16% | JP Morgan | Jessica Fye68% | $145 → $140 | Maintains | Neutral | Get Alert |
04/10/2023 | Buy Now | 322.74% | JP Morgan | Jessica Fye68% | $127 → $145 | Maintains | Neutral | Get Alert |
03/13/2023 | Buy Now | 424.78% | TD Cowen | Tyler Van Buren48% | $150 → $180 | Upgrade | Market Perform → Outperform | Get Alert |
03/02/2023 | Buy Now | 483.09% | RBC Capital | Luca Issi40% | → $200 | Initiates | → Outperform | Get Alert |
02/28/2023 | Buy Now | 483.09% | Deutsche Bank | Emmanuel Papadakis48% | $225 → $200 | Maintains | Buy | Get Alert |
02/24/2023 | Buy Now | 171.14% | SVB Leerink | Mani Foroohar46% | $111 → $93 | Downgrade | Market Perform → Underperform | Get Alert |
02/08/2023 | Buy Now | 302.33% | JP Morgan | Jessica Fye68% | $132 → $138 | Maintains | Neutral | Get Alert |
01/25/2023 | Buy Now | 337.32% | Cowen & Co. | Tyler Van Buren48% | $130 → $150 | Maintains | Market Perform | Get Alert |
01/24/2023 | Buy Now | 497.67% | Morgan Stanley | Matthew Harrison60% | $209 → $205 | Maintains | Equal-Weight | Get Alert |
01/18/2023 | Buy Now | 223.62% | SVB Leerink | Mani Foroohar46% | $102 → $111 | Maintains | Market Perform | Get Alert |
01/18/2023 | Buy Now | 506.41% | Chardan Capital | Geulah Livshits46% | $191 → $208 | Maintains | Neutral | Get Alert |
12/20/2022 | Buy Now | 532.65% | Piper Sandler | Edward Tenthoff52% | $214 → $217 | Maintains | Overweight | Get Alert |
12/19/2022 | Buy Now | 701.75% | Jefferies | Michael Yee56% | $170 → $275 | Upgrade | Hold → Buy | Get Alert |
12/16/2022 | Buy Now | 509.33% | Morgan Stanley | Matthew Harrison60% | $170 → $209 | Maintains | Equal-Weight | Get Alert |
12/14/2022 | Buy Now | 456.85% | Chardan Capital | Geulah Livshits46% | $186 → $191 | Downgrade | Buy → Neutral | Get Alert |
The latest price target for Moderna (NASDAQ:MRNA) was reported by JP Morgan on March 21, 2025. The analyst firm set a price target for $33.00 expecting MRNA to fall to within 12 months (a possible -3.79% downside). 60 analyst firms have reported ratings in the last year.
The latest analyst rating for Moderna (NASDAQ:MRNA) was provided by JP Morgan, and Moderna maintained their underweight rating.
The last upgrade for Moderna Inc happened on November 18, 2024 when HSBC raised their price target to $58. HSBC previously had a hold for Moderna Inc.
The last downgrade for Moderna Inc happened on February 18, 2025 when Barclays changed their price target from $111 to $45 for Moderna Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Moderna, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Moderna was filed on March 21, 2025 so you should expect the next rating to be made available sometime around March 21, 2026.
While ratings are subjective and will change, the latest Moderna (MRNA) rating was a maintained with a price target of $40.00 to $33.00. The current price Moderna (MRNA) is trading at is $34.30, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.